ArticleJournal of diabetes and metabolic disorders2026
Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management.
Article in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Real-time continuous glucose monitoring (RT-CGM) is increasingly used to support glycemic optimization and enhance diabetes self-management. However, evidence regarding its clinical and behavioral effects in adults with type 2 diabetes (T2D) who are not using intensive insulin therapy remains limited. Methods: This prospective, single-arm, 12-week study evaluated adults with T2D and suboptimal glycemic control (HbA1c > 7.0%) who were not using intensive insulin therapy and subsequently initiated RT-CGM. Clinical, metabolic, and glycemic parameters, as well as patient-reported outcomes assessed using the Diabetes Self-Management Questionnaire (DSMQ), were recorded. CGM metrics, including time in range (%TIR Results: A total of 118 participants were included in the study. RT-CGM use was associated with improved HbA1c (MD - 0.44%, Conclusion: Twelve weeks of RT-CGM use were associated with improvements in glycemic control, reductions in insulin requirements, favorable changes in CGM-derived risk metrics, and enhanced diabetes self-management behaviors in adults with T2D managed with non-intensive insulin regimens. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-026-01982-9.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.